Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penson

Showing results (351-360 of 1,177) with videos related to

Pageof 118
Sort By:
Expert Review of Clinical Pharmacology|July 27, 2023
Therapeutic drug monitoring: applying the 'Goldilocks Principle' to clinical pharmacologyPeter E Penson, Alice P McCloskey
BJU International|November 22, 2016
'Killing two birds with one stone': patient-reported quality-of-life outcomes from the Prostate Testing for Cancer and Treatment (ProtecT) trialMark D Tyson, David F Penson
The Journal of Urology|April 22, 2014
Re: use of statins and the risk of death in patients with prostate cancerSamir S Taneja, David F Penson
Expert Opinion on Investigational Drugs|January 10, 2017
Evaluating bempedoic acid for the treatment of hyperlipidaemiaPeter Penson, Mary McGowan, Maciej Banach
Journal of the American College Health Association|June 1, 1974
Birth control clinic: education and clinical servicesA B Penson, E D Mattmiller
The Journal of Urology|April 19, 2013
Re: survival after treatment for carcinoma invading bladder muscle: a dutch population-based study on the impact of hospital volumeDavid P Wood, David P Penson
The Journal of Urology|June 1, 1995
Segmental testicular infarction in the neonate: a case reportD F Penson, W J Aronson
The Oncologist|October 27, 2005
Topotecan: weighing in when there are many optionsRichard T Penson, Michael V Seiden
Journal of the National Cancer Institute|March 4, 2014
ResponseRichard M Hoffman, David F Penson
BJU International|May 23, 2008
Invasive T1 bladder cancer: indications and rationale for radical cystectomyJohn P Stein, David F Penson
Pageof 118

Showing results (351-360 of 1,177) with videos related to

Sort By:
Pageof 118
Expert Review of Clinical Pharmacology|July 27, 2023
Therapeutic drug monitoring: applying the 'Goldilocks Principle' to clinical pharmacologyPeter E Penson, Alice P McCloskey
BJU International|November 22, 2016
'Killing two birds with one stone': patient-reported quality-of-life outcomes from the Prostate Testing for Cancer and Treatment (ProtecT) trialMark D Tyson, David F Penson
The Journal of Urology|April 22, 2014
Re: use of statins and the risk of death in patients with prostate cancerSamir S Taneja, David F Penson
Expert Opinion on Investigational Drugs|January 10, 2017
Evaluating bempedoic acid for the treatment of hyperlipidaemiaPeter Penson, Mary McGowan, Maciej Banach
Journal of the American College Health Association|June 1, 1974
Birth control clinic: education and clinical servicesA B Penson, E D Mattmiller
The Journal of Urology|April 19, 2013
Re: survival after treatment for carcinoma invading bladder muscle: a dutch population-based study on the impact of hospital volumeDavid P Wood, David P Penson
The Journal of Urology|June 1, 1995
Segmental testicular infarction in the neonate: a case reportD F Penson, W J Aronson
The Oncologist|October 27, 2005
Topotecan: weighing in when there are many optionsRichard T Penson, Michael V Seiden
Journal of the National Cancer Institute|March 4, 2014
ResponseRichard M Hoffman, David F Penson
BJU International|May 23, 2008
Invasive T1 bladder cancer: indications and rationale for radical cystectomyJohn P Stein, David F Penson
Pageof 118